Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03818659 · ClinicalTrials.gov registry record · NA
Improving BP Control in Diverse Populations Using BP MAP
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 1,238,835
- Enrollment target
NCT03818659 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 1,238,835 participants.
The verdict
NCT03818659, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,238,835 participants
- Enrollment target
Study Summary
BP-MAP is a cluster randomized controlled trial (RCT) designed to compare the effectiveness of BP lowering from a clinic-based quality improvement program with Full Support (dedicated practice facilitation) vs. a Self-Guided version of the program. The American Medical Association (AMA) developed the framework for the interventions.
Interventions
- OTHER Self-Guided M.A.P. BP Improvement Program
- OTHER Full Support M.A.P. BP Improvement Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,238,835 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03818659
The ClinicalTrials.gov registry entry for NCT03818659 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,238,835 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Self-Guided M.A.P. BP Improvement Program is the first listed.
NCT03818659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03818659 about?
NCT03818659 is a clinical study titled "Improving BP Control in Diverse Populations Using BP MAP". BP-MAP is a cluster randomized controlled trial (RCT) designed to compare the effectiveness of BP lowering from a clinic-based quality improvement program with Full Support (dedicated practice facilitation) vs. a Self-Guided version of the program. The American Medical Association (AMA) developed th...
What is the current status of trial NCT03818659?
This trial is currently completed. It is a NA study. The enrollment target is 1,238,835 participants. The study started on 2019-07-01. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT03818659?
The interventions under investigation include: Self-Guided M.A.P. BP Improvement Program (OTHER), Full Support M.A.P. BP Improvement Program (OTHER).
Who is sponsoring clinical trial NCT03818659?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.